This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Klinikum Der Universitat Munchen, Leibniz-Institut Für Naturstoff-Forschung Und Infektionsbiologie E.v. -Hans-Knöll-Institut- (Hki), University of Notre Dame Du Lac. Active years: 2021.
Company Filing History:
1 out of 4 
1 out of 2 
1 out of 387 
Years Active: 2021
Title: Julia Dreisbach: Innovator in Antimicrobial Compounds
Introduction
Julia Dreisbach is a notable inventor based in Munich, Germany. She has made significant contributions to the field of antimicrobial compounds, particularly in the treatment of infectious diseases caused by mycobacteria. Her work aims to address critical health issues affecting both humans and animals.
Latest Patents
Julia Dreisbach holds a patent for her invention titled "Antimicrobial compounds, their use for the treatment of mammalian infections and a new metabolic mechanism." This patent focuses on a new series of benzothiazinone compounds designed to treat diseases such as tuberculosis, Buruli ulcer, and leprosy. The compounds are characterized by a specific general formula that includes various substituents, showcasing her innovative approach to overcoming existing treatment challenges.
Career Highlights
Throughout her career, Julia has worked with prestigious institutions, including the University of Notre Dame Du Lac and the Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoll Institute. Her research has been pivotal in advancing the understanding and treatment of infectious diseases.
Collaborations
Julia has collaborated with notable colleagues such as Florian Kloss and Sebastian Schieferdecker. These partnerships have enhanced her research and contributed to the development of her innovative compounds.
Conclusion
Julia Dreisbach's work in antimicrobial compounds represents a significant advancement in the treatment of infectious diseases. Her innovative approach and dedication to research continue to impact the field positively.